Երկիր: Ավստրալիա
Լեզու: անգլերեն
Աղբյուրը: Department of Health (Therapeutic Goods Administration)
Clopidogrel hydrogen sulfate; clopidogrel
Sanofi-Aventis Australia Pty Ltd
Medicine Registered
Clopidogrel Sanofi-ccdsv16-cmiv1-02apr13 1 CLOPIDOGREL SANOFI* TABLETS _Clopidogrel _ CONSUMER MEDICINE INFORMATION Please read this leaflet carefully before you start taking Clopidogrel Sanofi. You may wish to keep it to read again. WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Clopidogrel Sanofi tablets. It does not contain all the available information. Some of the information it contains may not apply to you. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. In deciding to give you Clopidogrel Sanofi, your doctor has weighed the risks of you taking Clopidogrel Sanofi against the expected benefits it will have for you. Always follow the instructions that your doctor and pharmacist give you about Clopidogrel Sanofi tablets. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. WHAT IS CLOPIDOGREL SANOFI USED FOR CLOPIDOGREL SANOFI CONTAINS THE MEDICINE CLOPIDOGREL. CLOPIDOGREL SANOFI BELONGS TO A GROUP OF MEDICINES CALLED ANTI-PLATELET MEDICINES. Platelets are very small blood cells which clump together during blood clotting. By preventing this clumping, anti-platelet medicines reduce the chances of blood clots forming (a process called thrombosis). Clopidogrel Sanofi is used to prevent blood clots forming in hardened blood vessels (a process known as atherothrombosis) which can lead to events such as stroke, heart attack or death. You may have been prescribed Clopidogrel Sanofi to help prevent blood clots forming and to reduce the risk of stroke, heart attack and death because: YOU HAVE PREVIOUSLY SUFFERED A HEART ATTACK, STROKE OR HAVE A CONDITION KNOWN AS PERIPHERAL ARTERIAL DISEASE (LEG PAIN ON WALKING OR AT REST). YOU HAVE SUFFERED AC Կարդացեք ամբողջական փաստաթուղթը